Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

Objective: To better understand immune checkpoint inhibitor (ICI)-induced diabetes mellitus (DM) in cancer patients. Design and method: We present a case of ICI-induced diabetic ketoacidosis (DKA) and conduct a systematic review of the PubMed and Web of Science databases up to September 2021 to iden...

Full description

Bibliographic Details
Main Authors: Jia Liu, Yuequan Shi, Xiaoyan Liu, Dongming Zhang, Haoran Zhang, Minjiang Chen, Yan Xu, Jing Zhao, Wei Zhong, Mengzhao Wang
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Translational Oncology
Subjects:
Cancer immunotherapy
Immune related adverse events
Immune-induced diabetes mellitus
Diabetic ketoacidosis
Pancreatic injury
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322001322

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322001322

Similar Items